Experts at the University of Maryland Marlene and Stewart Greenebaum Cancer Center are leading the way in discovering new ways to win the battle against cancer.
The University of Maryland Department of Radiation Oncology is one of the top 10 radiation oncology departments in the country in the amount of federal funding it receives for cutting-edge research.
Faculty members received a total of $13.4 million in funding from the National Institutes of Health (NIH), making the program sixth in the nation in funding for 2005, the latest year for which data is available and recently published.
“This is a testament to our outstanding faculty and our commitment to research that ultimately benefits patients,” says William F. Regine, M.D., professor and chairman of Radiation Oncology. “Our medical physics, clinical and radiobiology faculty are nationally recognized for their contributions to new knowledge about the uses of radiation therapy to treat cancer.”
Patients at the University of Maryland Marlene and Stewart Greenebaum Cancer Center (UMGCC) are the beneficiaries, since they have access to clinical trials testing new therapies that are not yet commercially available. UMGCC is currently conducting more that 150 clinical trials to find new and better ways to treat cancer patients.
The Department of Radiation Oncology has 11 medical physicists, eight radiobiology faculty and 10 clinical faculty members.
For more information on research activities in the Department of Radiation Oncology, call 410-328-2326.